These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32685378)

  • 21. [Intra-leukocyte cystine in cystinosis treated with cysteamine].
    Ged C; Jean G; Tete MJ; Broyer M; Kamoun P
    Ann Biol Clin (Paris); 1991; 49(9):482-6. PubMed ID: 1789502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Update on nephropathic cystinosis.
    Schneider JA; Katz B; Melles RB
    Pediatr Nephrol; 1990 Nov; 4(6):645-53. PubMed ID: 2088469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of cystinosis with delayed-release cysteamine: 6-year follow-up.
    Dohil R; Cabrera BL
    Pediatr Nephrol; 2013 Mar; 28(3):507-10. PubMed ID: 23001048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cysteamine in renal transplantation: A report of two patients with nephropathic cystinosis and the successful re-initiation of cysteamine therapy during the immediate post-transplant period.
    Berryhill A; Bhamre S; Chaudhuri A; Concepcion W; Grimm PC
    Pediatr Transplant; 2016 Feb; 20(1):141-5. PubMed ID: 26477696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management dilemmas in pediatric nephrology: Cystinosis.
    Besouw MT; Van Dyck M; Cassiman D; Claes KJ; Levtchenko EN
    Pediatr Nephrol; 2015 Aug; 30(8):1349-60. PubMed ID: 25956701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Phase 1 Pharmacokinetic Study of Cysteamine Bitartrate Delayed-Release Capsules Following Oral Administration with Orange Juice, Water, or Omeprazole in Cystinosis.
    Armas D; Holt RJ; Confer NF; Checani GC; Obaidi M; Xie Y; Brannagan M
    Adv Ther; 2018 Feb; 35(2):199-209. PubMed ID: 29411268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystinosis: renal glomerular and renal tubular function in relation to compliance with cystine-depleting therapy.
    Nesterova G; Williams C; Bernardini I; Gahl WA
    Pediatr Nephrol; 2015 Jun; 30(6):945-51. PubMed ID: 25526929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the prognosis of nephropathic cystinosis.
    Besouw MT; Levtchenko EN
    Int J Nephrol Renovasc Dis; 2014; 7():297-302. PubMed ID: 25114580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-up and treatment of adults with cystinosis in the Netherlands.
    Geelen JM; Monnens LA; Levtchenko EN
    Nephrol Dial Transplant; 2002 Oct; 17(10):1766-70. PubMed ID: 12270982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized clinical trial of topical cysteamine disulfide (cystamine) versus free thiol (cysteamine) in the treatment of corneal cystine crystals in cystinosis.
    Iwata F; Kuehl EM; Reed GF; McCain LM; Gahl WA; Kaiser-Kupfer MI
    Mol Genet Metab; 1998 Aug; 64(4):237-42. PubMed ID: 9758713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cysteamine prevents inhibition of adenylate kinase caused by cystine in rat brain cortex.
    Figueiredo VC; Feksa LR; Wannmacher CM
    Metab Brain Dis; 2009 Dec; 24(4):723-31. PubMed ID: 19437111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-invasive measurements of atherosclerosis in adult cystinosis patients.
    Besouw MT; Holewijn S; Levtchenko EN; Janssen MC
    J Inherit Metab Dis; 2011 Jun; 34(3):811-8. PubMed ID: 21305353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystinosis: a new perspective.
    Veys KR; Besouw MT; Pinxten AM; Dyck MV; Casteels I; Levtchenko EN
    Acta Clin Belg; 2016 Jun; 71(3):131-7. PubMed ID: 25560059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new gel formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis: the Cystadrops OCT-1 study.
    Labbé A; Baudouin C; Deschênes G; Loirat C; Charbit M; Guest G; Niaudet P
    Mol Genet Metab; 2014 Mar; 111(3):314-320. PubMed ID: 24440466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of oral phosphocysteamine and rectal cysteamine in cystinosis.
    van't Hoff WG; Baker T; Dalton RN; Duke LC; Smith SP; Chantler C; Haycock GB
    Arch Dis Child; 1991 Dec; 66(12):1434-7. PubMed ID: 1776892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding intestinal cysteamine bitartrate absorption.
    Dohil R; Fidler M; Barshop BA; Gangoiti J; Deutsch R; Martin M; Schneider JA
    J Pediatr; 2006 Jun; 148(6):764-9. PubMed ID: 16769383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cysteamine restores glutathione redox status in cultured cystinotic proximal tubular epithelial cells.
    Wilmer MJ; Kluijtmans LA; van der Velden TJ; Willems PH; Scheffer PG; Masereeuw R; Monnens LA; van den Heuvel LP; Levtchenko EN
    Biochim Biophys Acta; 2011 Jun; 1812(6):643-51. PubMed ID: 21371554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of cysteamine and other thiols on cystine egress from isolated lysosome-rich fractions of cystinotic and normal leucocytes.
    Steinherz R; Tietze F; Schulman JD
    Clin Chim Acta; 1983 Jul; 132(1):17-22. PubMed ID: 6616859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A New and Rapid LC-MS/MS Method for the Determination of Cysteamine Plasma Levels in Cystinosis Patients.
    Simeoli R; Cairoli S; Greco M; Bellomo F; Mancini A; Rossi C; Dionisi Vici C; Emma F; Goffredo BM
    Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of topical cysteamine in nephropathic cystinosis.
    Al-Hemidan A; Shoughy SS; Kozak I; Tabbara KF
    Br J Ophthalmol; 2017 Sep; 101(9):1234-1237. PubMed ID: 28057644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.